Literature DB >> 31028199

CCL21 Induces mTOR-dependent MALAT1 Expression, Leading to Cell Migration in Cutaneous T-Cell Lymphoma.

Chien-Hui Hong1,2, Shang-Hung Lin3, Chih-Hung Lee4.   

Abstract

BACKGROUND: Mycosis fungoides (MF) is indolent, but may disseminate to leukemia. We reported that C-C motif chemokine ligand 21 (CCL21) is associated with MF invasion and progression. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long noncoding RNA, is associated with several cancer types, however, how it interacts with CCL21 to regulate MF progression, remains unclear.
MATERIALS AND METHODS: Expression of long noncoding RNAs MALAT1, antisense noncoding RNA in the INK4 locus (ANRIL), Hox antisense intergenic RNA (HOTAIR), highly up-regulated in liver cancer RNA (HULC), and leukemia-associated non-coding insulin-like growth factor 1 receptor activator RNA 1 (LUNAR1) in tissues from MF was studied using polymerase chain reaction and RNA interference in MF cell line MyLa were used to address this question.
RESULTS: Expression of MALAT1 was selectively increased in MF tissues. C-C Chemokine receptor type 7 (CCR7) expression was found to be increased in MyLa cells. CCL21 was found not only to mediate migration, but also to enhance MALAT1 and mammalian target of rapamycin (mTOR) activation in MyLa cells. Knockdown of MALAT1 abrogated CCL21-mediated migration, but not mTOR activation. In contrast, mTOR inhibition reduced CCL21-mediated migration and MALAT1 expression.
CONCLUSION: CCL21 induced mTOR activation in MyLa cells, followed by expression of MALAT1, causing cell migration. MALAT1 and mTOR are potential therapeutic targets for MF. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  MALAT1; Mycosis fungoides; lncRNA; mTOR; migration

Mesh:

Substances:

Year:  2019        PMID: 31028199      PMCID: PMC6559909          DOI: 10.21873/invivo.11541

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  10 in total

Review 1.  C-C Chemokine Receptor 7 in Cancer.

Authors:  Colin A Bill; Christopher M Allen; Charlotte M Vines
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

Review 2.  Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome.

Authors:  Cristina Cristofoletti; Antonella Bresin; Martina Fioretti; Giandomenico Russo; Maria Grazia Narducci
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

3.  Single-Cell Analysis Reveals Transcriptomic Reprogramming in Aging Cardiovascular Endothelial Cells.

Authors:  Bo Gou; Xiaojing Chu; Yi Xiao; Pinxuan Liu; Hao Zhang; Zeyu Gao; Moshi Song
Journal:  Front Cardiovasc Med       Date:  2022-05-09

4.  CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma.

Authors:  Qianmei Fu; Xiaohong Tan; Huaming Tang; Jijiang Liu
Journal:  J Transl Med       Date:  2021-05-17       Impact factor: 5.531

5.  CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis.

Authors:  Xiao Jiang; Jingpeng Liu; Simin Li; Bo Jia; Zhijie Huang; Jun Shen; Haiyun Luo; Jianjiang Zhao
Journal:  Cell Death Dis       Date:  2020-09-18       Impact factor: 8.469

6.  Transcriptional changes in dendritic cells underlying allergen specific induced tolerance in a mouse model.

Authors:  Rafael Nuñez; Maria Jose Rodriguez; James Richard Perkins; Cristobalina Mayorga; Francisca Palomares; Francisca Gomez; Fernando M Jabato; Jose Cordoba-Caballero; Pedro Seoane; Jorge Losada; Javier Rojo; Maria Jose Torres
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.379

Review 7.  Noncoding RNAs as sensors of tumor microenvironmental stress.

Authors:  Yue Lv; Yinghao Lv; Zhen Wang; Kefei Yuan; Yong Zeng
Journal:  J Exp Clin Cancer Res       Date:  2022-07-16

8.  Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment.

Authors:  Wei Guo; Guang-Ming Liu; Ji-Yu Guan; Yu-Jia Chen; Yang-Zhi Zhao; Kun Wang; Ou Bai
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

9.  Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma.

Authors:  Christoph Roderburg; Sven H Loosen; Jan Bednarsch; Patrick H Alizai; Anjali A Roeth; Sophia M Schmitz; Mihael Vucur; Mark Luedde; Pia Paffenholz; Frank Tacke; Christian Trautwein; Tom F Ulmer; Ulf Peter Neumann; Tom Luedde
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

Review 10.  Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.

Authors:  Jing Jin; Qijie Zhao
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.